Role of Immunotherapy in Triple-Negative Breast Cancer

被引：438

作者：

Keenan, Tanya E. ^{[1
,2
]}

Tolaney, Sara M. ^{[1
,2
]}

机构：

[1] Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02115 USA

[2] Harvard Med Sch, Boston, MA 02115 USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2020年 / 18卷 / 04期

关键词：

PHASE-II; T-CELLS; PEMBROLIZUMAB; CHEMOTHERAPY; EFFICACY; PD-L1; BLOCKADE; RECEPTOR; SAFETY; LYMPHOCYTES;

D O I：

10.6004/jnccn.2020.7554

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Immune checkpoint inhibitors (ICIs) have led to durable clinical remissions in many metastatic cancers. However, the single-agent efficacy of ICIs in breast cancer is low, including in triple-negative breast cancer (TNBC), which has several key characteristics that enhance ICI responses. Strategies to improve anticancer immune responses in TNBC are urgently needed to extend survival for patients with metastatic disease. This review presents ICI monotherapy response rates and discusses combination strategies with chemotherapy, targeted therapies, and novel immunotherapies. It concludes with a summary of immunotherapy biomarkers in TNBC and a call to action for future directions of research critical to advancing the efficacy of immunotherapy for patients with TNBC.

引用

页码：479 / 489

页数：11

共 83 条

[1] Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study [J].

Adams, S. ;

Loi, S. ;

Toppmeyer, D. ;

Cescon, D. W. ;

De Laurentiis, M. ;

Nanda, R. ;

Winer, E. P. ;

Mukai, H. ;

Tamura, K. ;

Armstrong, A. ;

Liu, M. C. ;

Iwata, H. ;

Ryvo, L. ;

Wimberger, P. ;

Rugo, H. S. ;

Tan, A. R. ;

Jia, L. ;

Ding, Y. ;

Karantza, V. ;

Schmid, P. .

ANNALS OF ONCOLOGY, 2019, 30 (03) :405-411

[2] Atezolizumab Plus nab-Paclitaxel in the Treatment of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-up A Phase 1b Clinical Trial [J].

Adams, Sylvia ;

Diamond, Jennifer R. ;

Hamilton, Erika ;

Pohlmann, Paula R. ;

Tolaney, Sara M. ;

Chang, Ching-Wei ;

Zhang, Wei ;

Iizuka, Koho ;

Foster, Paul G. ;

Molinero, Luciana ;

Funke, Roel ;

Powderly, John .

JAMA ONCOLOGY, 2019, 5 (03) :334-342

[3]

[Anonymous], CANC RES S

[4]

[Anonymous], 2019, J CLIN ONCOL S

[5]

[Anonymous], 2019, CANC RES S

[6]

[Anonymous], 2019, ANN ONCOL, DOI DOI 10.1093/ANNONC/MDZ394

[7]

[Anonymous], 2018, CANC RES

[8]

[Anonymous], CANC RES S

[9]

[Anonymous], 2019, 2019 SAN ANT BREAST

[10]

[Anonymous], CANC RES S

← 1 2 3 4 5 6 7 8 9 →